• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


2.1100 USD 0.0728 3.57%

As of 20:10:00 ET on 12/26/2014.

Snapshot for GenVec Inc (GNVC)

Open: 2.0500 Day's Range: 2.0310 - 2.1100 Volume: 28,292
Previous Close: 2.0372 52wk Range: 1.6110 - 4.2500 1-Yr Rtn: -2.31%

Stock Chart for GNVC

No chart data available.
  • GNVC:US 2.1100
  • 1D
  • 1M
  • 1Y
Interactive GNVC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNVC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3400
Est. EPS (USD) (12/2014) -0.1750
Est. PEG Ratio -
Market Cap (M USD) 36.44
Shares Outstanding (M) 17.27
30 Day Average Volume 53,299
Price/Book (mrq) 3.1850
Price/Sale (ttm) 11.0835
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNVC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GNVC

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal cancer, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.

Douglas J SwirskyPresident/CEO/SecretaryDouglas E BroughChief Scientific Officer
James V LambertCFO/Treasurer/ControllerBryan T ButmanSenior VP:Development
More Company Profile & Key Executives for GNVC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil